GPR183 antagonist-3 (compound 33) is an oral active GPR183 antagonist with the IC 50 of 8.7 μM. GPR183 antagonist-3 displays strong in vitro antimigration and anti-inflammatory activity in monocytes, and improves the pathological symptoms of DSS-induced experimental colitis.